3B Blackbio [3BBLACKBIO] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

3B Blackbio Diagnostics Ltd.

BSE
Loading...

Panacea Biotec Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: 3B Blackbio Diagnostics Ltd. wins in 13 metrics, Panacea Biotec Ltd. wins in 6 metrics, with 0 ties. 3B Blackbio Diagnostics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric 3B Blackbio Diagnostics Ltd. Panacea Biotec Ltd. Better
P/E Ratio (TTM) 20.80 182.62 3B Blackbio Diagnostics Ltd.
Price-to-Book Ratio 3.89 2.65 Panacea Biotec Ltd.
Debt-to-Equity Ratio 0.09 2.79 3B Blackbio Diagnostics Ltd.
PEG Ratio 0.34 -15.02 3B Blackbio Diagnostics Ltd.
EV/EBITDA 20.17 -65.87 3B Blackbio Diagnostics Ltd.
Profit Margin (TTM) 44.56% -1.29% 3B Blackbio Diagnostics Ltd.
Operating Margin (TTM) 42.39% 1.99% 3B Blackbio Diagnostics Ltd.
EBITDA Margin (TTM) 42.39% 1.99% 3B Blackbio Diagnostics Ltd.
Return on Equity 17.60% -1.01% 3B Blackbio Diagnostics Ltd.
Return on Assets (TTM) 16.13% -0.65% 3B Blackbio Diagnostics Ltd.
Free Cash Flow (TTM) $424.53M $-776.74M 3B Blackbio Diagnostics Ltd.
1-Year Return -24.89% -22.18% Panacea Biotec Ltd.
Price-to-Sales Ratio (TTM) 9.21 3.61 Panacea Biotec Ltd.
Enterprise Value $11.32B $19.26B Panacea Biotec Ltd.
EV/Revenue Ratio 8.78 3.18 Panacea Biotec Ltd.
Gross Profit Margin (TTM) 72.47% 58.88% 3B Blackbio Diagnostics Ltd.
Revenue per Share (TTM) $152 $99 3B Blackbio Diagnostics Ltd.
Earnings per Share (Diluted) $66.57 $-1.28 3B Blackbio Diagnostics Ltd.
Beta (Stock Volatility) 0.47 0.14 Panacea Biotec Ltd.

3B Blackbio Diagnostics Ltd. vs Panacea Biotec Ltd. Stock Performance Analysis

Loading Price Chart...

3BBLACKBIO
PANACEABIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
3B Blackbio Diagnostics Ltd.-0.73%-7.13%-9.11%-6.85%-11.83%-19.55%
Panacea Biotec Ltd.20.00%4.95%16.18%35.33%23.76%14.82%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
3B Blackbio Diagnostics Ltd.-24.89%58.97%58.97%58.97%58.97%58.97%
Panacea Biotec Ltd.-22.18%242.47%5.32%298.85%175.16%35.76%

Performance & Financial Health Analysis: 3B Blackbio Diagnostics Ltd. vs Panacea Biotec Ltd.

Metric3BBLACKBIOPANACEABIO
Market Information
Market Cap i₹11.13B₹21.84B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i12,508168,211
90 Day Avg. Volume i12,860144,184
Last Close₹1,129.75₹520.30
52 Week Range₹1,083.50 - ₹1,750.00₹292.40 - ₹520.30
% from 52W High-35.44%0.00%
All-Time High₹2,350.00 (Dec 09, 2024)₹581.90 (Apr 28, 2025)
% from All-Time High-51.93%-10.59%
Growth Metrics
Quarterly Revenue Growth0.98%0.01%
Quarterly Earnings Growth0.62%-0.12%
Financial Health
Profit Margin (TTM) i0.45%-0.01%
Operating Margin (TTM) i0.42%0.02%
Return on Equity (TTM) i0.18%-0.01%
Debt to Equity (MRQ) i0.092.79
Cash & Liquidity
Book Value per Share (MRQ)₹355.75₹134.77
Cash per Share (MRQ)₹27.44₹13.86
Operating Cash Flow (TTM) i₹619.97M₹-1,511,860,000
Levered Free Cash Flow (TTM) i₹476.91M₹-83,700,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: 3B Blackbio Diagnostics Ltd. vs Panacea Biotec Ltd.

Metric3BBLACKBIO (Apr 24, 2026)PANACEABIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i20.80182.62
Forward P/E iN/AN/A
PEG Ratio i0.34-15.02
Price to Sales (TTM) i9.213.61
Price to Book (MRQ) i3.892.65
Market Capitalization
Market Capitalization i₹11.13B₹21.84B
Enterprise Value i₹11.32B₹19.26B
Enterprise Value Metrics
Enterprise to Revenue i8.783.18
Enterprise to EBITDA i20.17-65.87
Risk & Other Metrics
Beta i0.470.14
Book Value per Share (MRQ) i₹355.75₹134.77

Financial Statements Comparison: 3B Blackbio Diagnostics Ltd. vs Panacea Biotec Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric3BBLACKBIO (2025)PANACEABIO (2025)
Revenue/Sales i964.69M4.93B
Cost of Goods Sold i256.46M2.36B
COGS % of Revenue i26.6%47.9%
Gross Profit i708.23M2.57B
Gross Margin i73.4%52.1%
Research & Development i5.12MN/A
Operating Income (EBIT) i493.22M-556.12M
Operating Margin i51.1%-11.3%
EBITDA i591.08M-76.28M
EBITDA Margin i61.3%-1.5%
Pre-Tax Income i639.98M-79.48M
Pre-Tax Income % of Revenue i66.3%-1.6%
Income Tax i163.07M7.71M
Income Tax % of Revenue i16.9%0.2%
Net Income (Profit) i476.91M-87.19M
Profit Margin i49.4%-1.8%

Balance Sheet & Liquidity Metrics

Metric3BBLACKBIO (2025)PANACEABIO (2025)
Cash & Equivalents i117.07M821.25M
Total Current Assets i1.32B5.45B
Total Current Assets % of Revenue i137.0%110.7%
Total Current Liabilities i185.88M3.67B
Total Current Liabilities % of Revenue i19.3%74.5%
Long-Term Debt i3.07M150.00M
Long-Term Debt % of Revenue i0.3%3.0%
Total Shareholders Equity i2.71B8.31B
Retained Earnings i2.51B7.80B
Retained Earnings % of Revenue i259.9%158.3%
Property, Plant & Equipment i85.37M5.43B

Cash Flow Statement Comparison

Metric3BBLACKBIO (2025)PANACEABIO (2025)
Operating Cash Flow i619.97M-1.51B
Operating Cash Flow % of Revenue i64.3%-30.7%
Capital Expenditures i-9.04M-497.30M
Free Cash Flow i424.53M-776.74M
FCF Margin i44.0%-15.8%
Debt Repayment i-5.44M0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

Metric3BBLACKBIOPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.58M61.25M
Float Shares i2.69M15.42M
% Held by Insiders i65.90%72.65%
% Held by Institutions i1.95%0.13%
% Held by Public i32.15%27.22%

Dividend Analysis & Yield Comparison: 3B Blackbio Diagnostics Ltd. vs Panacea Biotec Ltd.

Metric3BBLACKBIOPANACEABIO
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A